5 Key Takeaways

• 1

  Platelet-rich plasma (PRP) enhances nerve growth and improves gland function in patients with dry eye and neuropathic pain.

• 2

  PRP is richer in anti-inflammatory mediators and growth factors than autologous serum (AS), yielding superior results in treatment.

• 3

  A new PRP formulation was developed to prevent clotting and bacterial growth while maintaining efficacy for long-term use as eye drops.

• 4

  Microneedling PRP around the meibomian and lacrimal glands enhances their function and may be safer than direct gland injections.

• 5

  PRP is increasingly recognized as a therapeutic option in ophthalmology, similar to its established use in other medical specialties.